GlobalData on MSN4 个月
Abbott starts new trial to assess early use benefit of HeartMate 3
The participants' pulmonary artery pressures (PAP) will be remotely monitored using Abbott's CardioMEMS HF system, implanted ...
来自MSN2 个月
Microplastics in Water; New NCD for CardioMEMS; Valve Surgery Amid Los Angeles Fires
(Journal of the American College of Cardiology) The Centers for Medicare & Medicaid Services expanded Medicare access to CardioMEMS with a new national coverage determination (NCD), Abbott ...
Yahoo Finance2 天
Abbott Laboratories (ABT)
The TEAM-HF trial, which is planned to enroll up to 850 patients across 75 sites worldwide, will measure pulmonary artery pressures (PAP) using Abbott's CardioMEMS™ HF System to objectively ...